Silencing of MBD1 and MeCP2 in prostatecancer-derived PC3 cells produces differential gene expression profiles and cellular phenotypes

Bioscience Reports

Volumn 28, Issue 6, 2008, Pages 319-326

  Yaqinuddin, Ahmed ^a   Abbas, Farhat ^a   Naqvi, Syed Z ^a   Bashir, Mohammad U ^a   Qazi, Romena ^a   Qureshi, Sohail A ^a  

^a AGA KHAN UNIVERSITY   (Pakistan)

Author keywords

DNA methylation; Gene expression; Methyl binding protein (MBP); Methylated CpG (mCpG); RNA interference (RNAi)

Indexed keywords

DNA BINDING PROTEIN; MBD1 PROTEIN, HUMAN; MECP2 PROTEIN, HUMAN; METHYL CPG BINDING PROTEIN 2; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; TUMOR PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER INVASION; CELL MOTION; CELL TRANSFORMATION; CPG ISLAND; DNA METHYLATION; DNA MICROARRAY; DRUG ANTAGONISM; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MALE; METABOLISM; PATHOLOGY; PROSTATE TUMOR; RNA INTERFERENCE; TUMOR CELL LINE;

APOPTOSIS; CELL LINE, TUMOR; CELL MOVEMENT; CELL TRANSFORMATION, NEOPLASTIC; CPG ISLANDS; DNA METHYLATION; DNA-BINDING PROTEINS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; METHYL-CPG-BINDING PROTEIN 2; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROSTATIC NEOPLASMS; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSCRIPTION FACTORS;

EID: 60249094056     PISSN: 01448463     EISSN: 15734935     Source Type: Journal    
DOI: 10.1042/BSR20080032     Document Type: Article

References (30)

1. Esteller, M. (2007) Cancer epigenomics: DNA methylomes and histone-modification maps. Nat. Rev. Genet. 8, 286-298
2. Zhang, Z., Sun, D., Van do, N., Tang, A., Hu, L. and Huang, G. (2007) Inactivation of RASSF2A by promoter methylation correlates with lymph node metastasis in nasopharyngeal carcinoma. Int. J. Cancer 120, 32-38
3. Sakuma, M., Akahira, J., Ito, K., Niikura, H., Moriya, T., Okamura, K., Sasano, H. and Yaegashi, N. (2007) Promoter methylation status of the cyclin D2 gene is associated with poor prognosis in human epithelial ovarian cancer. Cancer Sci. 98, 380-386
4. Yang, H. J., Liu, V. W., Wang, Y., Tsang, P. C. and Ngan, H. Y. (2006) Differential DNA methylation profiles in gynecological cancers and correlation with clinico-pathological data. BMC Cancer 6, 212
5. Liedtke, C., Zschemisch, N. H., Cohrs, A., Roskams, T., Borlak, J., Manns, M. P. and Trautwein, C. (2005) Silencing of caspase-8 in murine hepatocellular carcinomas is mediated via methylation of an essential promoter element. Gastroenterology 129, 1602-1615
6. Baylin, S. B. and Herman, J. G. (2000) DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet. 16, 168-174
7. Klose, R. J. and Bird, A. P. (2006) Genomic DNA methylation: the mark and its mediators. Trends Biochem. Sci. 31, 89-97
8. Sansom, O. J., Maddison, K. and Clarke, A. R. (2007) Mechanisms of disease: methyl-binding domain proteins as potential therapeutic targets in cancer. Nat. Clin. Pract. Oncol. 4, 305-315
9. Nan, X., Ng, H. H., Johnson, C. A., Laherty, C. D., Turner, B. M., Eisenman, R. N. and Bird, A. (1998) Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 393, 386-389
10. Koch, C. and Stratling, W. H. (2004) DNA binding of methyl-CpG-binding protein MeCP2 in human MCF7 cells. Biochemistry 43, 5011-5021
11. Klose, R. J., Sarraf, S. A., Schmiedeberg, L., McDermott, S. M., Stancheva, I. and Bird, A. P. (2005) DNA binding selectivity of MeCP2 due to a requirement for A/T sequences adjacent to methyl-CpG. Mol. Cell 19, 667-678
12. Zhang, Y., Ng, H. H., Erdjument-Bromage, H., Tempst, P., Bird, A. and Reinberg, D. (1999) Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation. Genes Dev. 13, 1924-1935
13. Kondo, E., Gu, Z., Horii, A. and Fukushige, S. (2005) The thymine DNA glycosylase MBD4 represses transcription and is associated with methylated p16(INK4a) and hMLH1 genes. Mol. Cell. Biol. 25, 4388-4396
14. Jorgensen, H. F., Ben-Porath, I. and Bird, A. P. (2004) Mbd1 is recruited to both methylated and nonmethylated CpGs via distinct DNA binding domains. Mol. Cell. Biol. 24, 3387-3395
15. Villa, R., Morey, L., Raker, V. A., Buschbeck, M., Gutierrez, A., De Santis, F., Corsaro, M., Varas, F., Bossi, D., Minucci, S. et al. (2006) The methyl-CpG binding protein MBD1 is required for PML-RARα function. Proc. Natl. Acad. Sci. U.S.A. 103, 1400-1405
16. Sarraf, S. A. and Stancheva, I. (2004) Methyl-CpG binding protein MBD1 couples histone H3 methylation at lysine 9 by SETDB1 to DNA replication and chromatin assembly. Mol. Cell 15, 595-605
17. Arunkumar, A., Vijayababu, M. R., Kanagaraj, P., Balasubramanian, K., Aruldhas, M. M. and Arunakaran, J. (2005) Growth suppressing effect of garlic compound diallyl disulfide on prostate cancer cell line (PC-3) in vitro. Biol. Pharm. Bull. 28, 740-743
18. Albini, A., Benelli, R., Noonan, D. M. and Brigati, C. (2004) The "chemoinvasion assay": a tool to study tumor and endothelial cell invasion of basement membranes. Int. J. Dev. Biol. 48, 563-571
19. Bernard, D., Gil, J., Dumont, P., Rizzo, S., Monte, D., Quatannens, B., Hudson, D., Visakorpi, T., Fuks, F. and de Launoit, Y. (2006) The methyl-CpG-binding protein MECP2 is required for prostate cancer cell growth. Oncogene 25, 1358-1366
20. O'Hagan, R. C., Ohh, M., David, G., de Alboran, I. M., Alt, F. W., Kaelin, Jr., W. G. and DePinho, R. A. (2000) Myc-enhanced expression of Cul1 promotes ubiquitin-dependent proteolysis and cell cycle progression. Genes Dev. 14, 2185-2191
21. Hermeking, H., Rago, C., Schuhmacher, M., Li, Q., Barrett, J. F., Obaya, A. J., O'Connell, B. C., Mateyak, M. K., Tam, W., Kohlhuber, F. et al. (2000) Identification of CDK4 as a target of c-MYC. Proc. Natl. Acad. Sci. U.S.A. 97, 2229-2234
22. Berns, K., Hijmans, E. M. and Bernards, R. (1997) Repression of c-Myc responsive genes in cycling cells causes G1 arrest through reduction of cyclin E/CDK2 kinase activity. Oncogene 15, 1347-1356
23. Wagner, A. J., Meyers, C., Laimins, L. A. and Hay, N. (1993) c-Myc induces the expression and activity of ornithine decarboxylase. Cell Growth Differ. 4, 879-883
24. Pfeifer, G. P. and Dammann, R. (2005) Methylation of the tumor suppressor gene RASSF1A in human tumors. Biochemistry (Moscow) 70, 576-583
25. Sears, R. C. (2004) The life cycle of c-myc: from synthesis to degradation. Cell Cycle 3, 1133-1137
26. Sears, R., Nuckolls, F., Haura, E., Taya, Y., Tamai, K. and Nevins, J. R. (2000) Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability. Genes Dev. 14, 2501-2514
27. Dietze, E. C., Caldwell, L. E., Marcom, K., Collins, S. J., Yee, L., Swisshelm, K., Hobbs, K. B., Bean, G. R. and Seewaldt, V. L. (2002) Retinoids and retinoic acid receptors regulate growth arrest and apoptosis in human mammary epithelial cells and modulate expression of CBP/p300. Microsc. Res. Tech. 59, 23-40
28. Ballestar, E., Paz, M. F., Valle, L., Wei, S., Fraga, M. F., Espada, J., Cigudosa, J. C., Huang, T. H. and Esteller, M. (2003) Methyl-CpG binding proteins identify novel sites of epigenetic inactivation in human cancer. EMBO J. 22, 6335-6345
29. Fujita, N., Shimotake, N., Ohki, I., Chiba, T., Saya, H., Shirakawa, M. and Nakao, M. (2000) Mechanism of transcriptional regulation by methyl-CpG binding protein MBD1. Mol. Cell. Biol. 20, 5107-5118
30. Georgel, P. T., Horowitz-Scherer, R. A., Adkins, N., Woodcock, C. L., Wade, P. A. and Hansen, J. C. (2003) Chromatin compaction by human MeCP2. Assembly of novel secondary chromatin structures in the absence of DNA methylation. J. Biol. Chem. 278, 32181-32188